{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:22:09Z","timestamp":1793924529094,"version":"4.8.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1750-1172-5-39","type":"journal-article","created":{"date-parts":[[2011,1,5]],"date-time":"2011-01-05T14:25:40Z","timestamp":1294237540000},"source":"Crossref","is-referenced-by-count":458,"title":["Toxic epidermal necrolysis and Stevens-Johnson syndrome"],"prefix":"10.1186","volume":"5","author":[{"given":"Thomas","family":"Harr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars E","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,16]]},"reference":[{"key":"202_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.129.1.92","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC: Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993, 129: 92-96. 10.1001\/archderm.129.1.92.","journal-title":"Arch Dermatol"},{"key":"202_CR2","first-page":"54","volume":"25","author":"N Fiessinger","year":"1917","unstructured":"Fiessinger N, Rendu R: Sur un syndrome charact\u00e9ris\u00e9 par l'inflammation simultan\u00e9e de toutes les muqueuses externes coexistant avec une \u00e9ruption v\u00e9siculeuse des quatre membres, non douloureuse et non recidivante. Paris m\u00e9dical. 1917, 25: 54-58.","journal-title":"Paris m\u00e9dical"},{"key":"202_CR3","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archpedi.1922.04120120077005","volume":"24","author":"AM Stevens","year":"1922","unstructured":"Stevens AM, Johnson FC: A new eruptive fever associated with stomatitis and ophtalmia; report of two cases in children. American Journal of Diseases in Children. 1922, 24: 526-533.","journal-title":"American Journal of Diseases in Children"},{"key":"202_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1365-2133.1956.tb12766.x","volume":"68","author":"A Lyell","year":"1956","unstructured":"Lyell A: Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol. 1956, 68: 355-361. 10.1111\/j.1365-2133.1956.tb12766.x.","journal-title":"Br J Dermatol"},{"key":"202_CR5","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/S0140-6736(98)05418-X","volume":"353","author":"B Rzany","year":"1999","unstructured":"Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R: Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. Lancet. 1999, 353: 2190-2194. 10.1016\/S0140-6736(98)05418-X.","journal-title":"Lancet"},{"key":"202_CR6","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2165\/00002018-200528100-00008","volume":"28","author":"L La Grenade","year":"2005","unstructured":"La Grenade L, Lee L, Weaver J, Bonnel R, Karwoski C, Governale L, Brinker A: Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors. Drug Saf. 2005, 28: 917-924. 10.2165\/00002018-200528100-00008.","journal-title":"Drug Saf"},{"key":"202_CR7","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1001\/archderm.131.10.1212","volume":"131","author":"HL Chan","year":"1995","unstructured":"Chan HL: Toxic epidermal necrolysis in Singapore, 1989 through 1993: incidence and antecedent drug exposure. Arch Dermatol. 1995, 131: 1212-1213. 10.1001\/archderm.131.10.1212.","journal-title":"Arch Dermatol"},{"key":"202_CR8","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","volume":"333","author":"JC Roujeau","year":"1995","unstructured":"Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F: Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995, 333: 1600-1607. 10.1056\/NEJM199512143332404.","journal-title":"N Engl J Med"},{"key":"202_CR9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/0190-9622(92)70082-Q","volume":"26","author":"P Saiag","year":"1992","unstructured":"Saiag P, Caumes E, Chosidow O, Revuz J, Roujeau JC: Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus. J Am Acad Dermatol. 1992, 26: 567-574. 10.1016\/0190-9622(92)70082-Q.","journal-title":"J Am Acad Dermatol"},{"key":"202_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00015550310002611","volume":"83","author":"A Rotunda","year":"2003","unstructured":"Rotunda A, Hirsch RJ, Scheinfeld N, Weinberg JM: Severe cutaneous reactions associated with the use of human immunodeficiency virus medications. Acta Derm Venereol. 2003, 83: 1-9. 10.1080\/00015550310002611.","journal-title":"Acta Derm Venereol"},{"key":"202_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1023\/B:NEON.0000014538.31561.bc","volume":"66","author":"D Aguiar","year":"2004","unstructured":"Aguiar D, Pazo R, Duran I, Terrasa J, Arrivi A, Manzano H, Martin J, Rifa J: Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider. J Neurooncol. 2004, 66: 345-350. 10.1023\/B:NEON.0000014538.31561.bc.","journal-title":"J Neurooncol"},{"key":"202_CR12","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1468-3083.2006.01510.x","volume":"20","author":"F Aydin","year":"2006","unstructured":"Aydin F, Cokluk C, Senturk N, Aydin K, Canturk MT, Turanli AY: Stevens-Johnson syndrome in two patients treated with cranial irradiation and phenytoin. J Eur Acad Dermatol Venereol. 2006, 20: 588-590. 10.1111\/j.1468-3083.2006.01510.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"202_CR13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/BF02113442","volume":"14","author":"S Fournier","year":"1995","unstructured":"Fournier S, Bastuji-Garin S, Mentec H, Revuz J, Roujeau JC: Toxic epidermal necrolysis associated with Mycoplasma pneumoniae infection. Eur J Clin Microbiol Infect Dis. 1995, 14: 558-559. 10.1007\/BF02113442.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"202_CR14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/0310057X0703500317","volume":"35","author":"JM Mulvey","year":"2007","unstructured":"Mulvey JM, Padowitz A, Lindley-Jones M, Nickels R: Mycoplasma pneumoniae associated with Stevens Johnson syndrome. Anaesth Intensive Care. 2007, 35: 414-417.","journal-title":"Anaesth Intensive Care"},{"key":"202_CR15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jaad.2004.07.044","volume":"52","author":"PC Schalock","year":"2005","unstructured":"Schalock PC, Dinulos JG: Mycoplasma pneumoniae-induced Stevens-Johnson syndrome without skin lesions: fact or fiction?. J Am Acad Dermatol. 2005, 52: 312-315. 10.1016\/j.jaad.2004.07.044.","journal-title":"J Am Acad Dermatol"},{"key":"202_CR16","doi-asserted-by":"publisher","first-page":"965","DOI":"10.2165\/00002018-200225130-00006","volume":"25","author":"R Forman","year":"2002","unstructured":"Forman R, Koren G, Shear NH: Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Drug Saf. 2002, 25: 965-972. 10.2165\/00002018-200225130-00006.","journal-title":"Drug Saf"},{"key":"202_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1067\/mjd.2003.107","volume":"48","author":"R Mandelcorn","year":"2003","unstructured":"Mandelcorn R, Shear NH: Lupus-associated toxic epidermal necrolysis: a novel manifestation of lupus?. J Am Acad Dermatol. 2003, 48: 525-529. 10.1067\/mjd.2003.107.","journal-title":"J Am Acad Dermatol"},{"key":"202_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1046\/j.1398-9995.2003.00336.x","volume":"59","author":"Y Aihara","year":"2004","unstructured":"Aihara Y, Ito S, Kobayashi Y, Aihara M: Stevens-Johnson syndrome associated with azithromycin followed by transient reactivation of herpes simplex virus infection. Allergy. 2004, 59: 118-10.1046\/j.1398-9995.2003.00336.x.","journal-title":"Allergy"},{"key":"202_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/sj.bmt.1703624","volume":"30","author":"JL Zakrzewski","year":"2002","unstructured":"Zakrzewski JL, Lentini G, Such U, Duerr A, Tran V, Guenzelmann S, Braunschweig T, Riede UN, Koldehoff M: Toxic epidermal necrolysis: differential diagnosis of an epidermolytic dermopathy in a hematopoietic stem cell transplant recipient. Bone Marrow Transplant. 2002, 30: 331-333. 10.1038\/sj.bmt.1703624.","journal-title":"Bone Marrow Transplant"},{"key":"202_CR20","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s001340050492","volume":"23","author":"F Lebargy","year":"1997","unstructured":"Lebargy F, Wolkenstein P, Gisselbrecht M, Lange F, Fleury-Feith J, Delclaux C, Roupie E, Revuz J, Roujeau JC: Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Intensive Care Med. 1997, 23: 1237-1244. 10.1007\/s001340050492.","journal-title":"Intensive Care Med"},{"key":"202_CR21","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1001\/archderm.123.9.1160","volume":"123","author":"J Revuz","year":"1987","unstructured":"Revuz J, Penso D, Roujeau JC, Guillaume JC, Payne CR, Wechsler J, Touraine R: Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol. 1987, 123: 1160-1165. 10.1001\/archderm.123.9.1160.","journal-title":"Arch Dermatol"},{"key":"202_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/ICO.0b013e31802eb264","volume":"26","author":"YS Chang","year":"2007","unstructured":"Chang YS, Huang FC, Tseng SH, Hsu CK, Ho CL, Sheu HM: Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management. Cornea. 2007, 26: 123-129. 10.1097\/ICO.0b013e31802eb264.","journal-title":"Cornea"},{"key":"202_CR23","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ophtha.2008.12.048","volume":"116","author":"C Sotozono","year":"2009","unstructured":"Sotozono C, Ueta M, Koizumi N, Inatomi T, Shirakata Y, Ikezawa Z, Hashimoto K, Kinoshita S: Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology. 2009, 116: 685-690. 10.1016\/j.ophtha.2008.12.048.","journal-title":"Ophthalmology"},{"key":"202_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1398-9995.2006.01295.x","volume":"62","author":"LW Yip","year":"2007","unstructured":"Yip LW, Thong BY, Lim J, Tan AW, Wong HB, Handa S, Heng WJ: Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series. Allergy. 2007, 62: 527-531. 10.1111\/j.1398-9995.2006.01295.x.","journal-title":"Allergy"},{"key":"202_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000070938","volume":"207","author":"S Magina","year":"2003","unstructured":"Magina S, Lisboa C, Leal V, Palmares J, Mesquita-Guimaraes J: Dermatological and ophthalmological sequels in toxic epidermal necrolysis. Dermatology. 2003, 207: 33-36. 10.1159\/000070938.","journal-title":"Dermatology"},{"key":"202_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1542\/peds.109.1.74","volume":"109","author":"RL Sheridan","year":"2002","unstructured":"Sheridan RL, Schulz JT, Ryan CM, Schnitzer JJ, Lawlor D, Driscoll DN, Donelan MB, Tompkins RG: Long-term consequences of toxic epidermal necrolysis in children. Pediatrics. 2002, 109: 74-78. 10.1542\/peds.109.1.74.","journal-title":"Pediatrics"},{"key":"202_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/01.bcr.0000194268.01514.f8","volume":"27","author":"A Oplatek","year":"2006","unstructured":"Oplatek A, Brown K, Sen S, Halerz M, Supple K, Gamelli RL: Long-term follow-up of patients treated for toxic epidermal necrolysis. J Burn Care Res. 2006, 27: 26-33. 10.1097\/01.bcr.0000194268.01514.f8.","journal-title":"J Burn Care Res"},{"key":"202_CR28","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/S0140-6736(85)90771-8","volume":"2","author":"JC Roujeau","year":"1985","unstructured":"Roujeau JC, Guillaume JC, Revuz J, Touraine R: Reporting adverse drug reactions. Lancet. 1985, 2: 1244-10.1016\/S0140-6736(85)90771-8.","journal-title":"Lancet"},{"key":"202_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/pgmj.67.784.195","volume":"67","author":"J Saban","year":"1991","unstructured":"Saban J, Pais JR, Rodriguez JL, Boixeda D: Sjogren-like pluriglandular exocrine insufficiency after drug-induced toxic epidermal necrolysis. Postgrad Med J. 1991, 67: 195-197. 10.1136\/pgmj.67.784.195.","journal-title":"Postgrad Med J"},{"key":"202_CR30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/428486a","volume":"428","author":"WH Chung","year":"2004","unstructured":"Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT: Medical genetics: a marker for Stevens-Johnson syndrome. Nature. 2004, 428: 486-10.1038\/428486a.","journal-title":"Nature"},{"key":"202_CR31","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","volume":"48","author":"CB Man","year":"2007","unstructured":"Man CB, Kwan P, Baum L, Yu E, Lau KM, Cheng AS, Ng MH: Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia. 2007, 48: 1015-1018. 10.1111\/j.1528-1167.2007.01022.x.","journal-title":"Epilepsia"},{"key":"202_CR32","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1528-1167.2010.02533.x","volume":"51","author":"W Tassaneeyakul","year":"2010","unstructured":"Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Chen P, Lin SY, Chen WH, Konyoung P, Khunarkornsiri U, Auvichayapat N, Pavakul K: Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. Epilepsia. 2010, 51: 926-930.","journal-title":"Epilepsia"},{"key":"202_CR33","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2217\/14622416.7.6.813","volume":"7","author":"A Alfirevic","year":"2006","unstructured":"Alfirevic A, Jorgensen AL, Williamson PR, Chadwick DW, Park BK, Pirmohamed M: HLA-B locus in Caucasian patients with carbamazepine hypersensitivity. Pharmacogenomics. 2006, 7: 813-818. 10.2217\/14622416.7.6.813.","journal-title":"Pharmacogenomics"},{"key":"202_CR34","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.2217\/14622416.9.11.1617","volume":"9","author":"N Kaniwa","year":"2008","unstructured":"Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, Sawada J, Furuya H, Takahashi Y, Muramatsu M: HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics. 2008, 9: 1617-1622. 10.2217\/14622416.9.11.1617.","journal-title":"Pharmacogenomics"},{"key":"202_CR35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.tpj.6500356","volume":"6","author":"C Lonjou","year":"2006","unstructured":"Lonjou C, Thomas L, Borot N, Ledger N, de Toma C, LeLouet H, Graf E, Schumacher M, Hovnanian A, Mockenhaupt M, Roujeau JC: A marker for Stevens-Johnson syndrome...: ethnicity matters. Pharmacogenomics J. 2006, 6: 265-268.","journal-title":"Pharmacogenomics J"},{"key":"202_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","volume":"18","author":"C Lonjou","year":"2008","unstructured":"Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, Naldi L, Bouwes-Bavinck JN, Sidoroff A, de Toma C: A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics. 2008, 18: 99-107. 10.1097\/FPC.0b013e3282f3ef9c.","journal-title":"Pharmacogenet Genomics"},{"key":"202_CR37","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0409500102","volume":"102","author":"SI Hung","year":"2005","unstructured":"Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, Lin YL, Lan JL, Yang LC, Hong HS: HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA. 2005, 102: 4134-4139. 10.1073\/pnas.0409500102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"202_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1345\/aph.19064","volume":"34","author":"A Halevi","year":"2000","unstructured":"Halevi A, Ben-Amitai D, Garty BZ: Toxic epidermal necrolysis associated with acetaminophen ingestion. Ann Pharmacother. 2000, 34: 32-34. 10.1345\/aph.19064.","journal-title":"Ann Pharmacother"},{"key":"202_CR39","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1528-1157.1983.tb04914.x","volume":"24","author":"D Schmidt","year":"1983","unstructured":"Schmidt D, Kluge W: Fatal toxic epidermal necrolysis following reexposure to phenytoin: a case report. Epilepsia. 1983, 24: 440-443. 10.1111\/j.1528-1157.1983.tb04914.x.","journal-title":"Epilepsia"},{"key":"202_CR40","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1001\/archderm.129.4.466","volume":"129","author":"O Correia","year":"1993","unstructured":"Correia O, Delgado L, Ramos JP, Resende C, Torrinha JA: Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement. Arch Dermatol. 1993, 129: 466-468. 10.1001\/archderm.129.4.466.","journal-title":"Arch Dermatol"},{"key":"202_CR41","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01119.x","volume":"119","author":"L Le Cleach","year":"2000","unstructured":"Le Cleach L, Delaire S, Boumsell L, Bagot M, Bourgault-Villada I, Bensussan A, Roujeau JC: Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol. 2000, 119: 225-230. 10.1046\/j.1365-2249.2000.01119.x.","journal-title":"Clin Exp Immunol"},{"key":"202_CR42","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","volume":"114","author":"A Nassif","year":"2004","unstructured":"Nassif A, Bensussan A, Boumsell L, Deniaud A, Moslehi H, Wolkenstein P, Bagot M, Roujeau JC: Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol. 2004, 114: 1209-1215. 10.1016\/j.jaci.2004.07.047.","journal-title":"J Allergy Clin Immunol"},{"key":"202_CR43","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/nm.1884","volume":"14","author":"WH Chung","year":"2008","unstructured":"Chung WH, Hung SI, Yang JY, Su SC, Huang SP, Wei CY, Chin SW, Chiou CC, Chu SC, Ho HC: Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med. 2008, 14: 1343-1350. 10.1038\/nm.1884.","journal-title":"Nat Med"},{"key":"202_CR44","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1126\/science.282.5388.490","volume":"282","author":"I Viard","year":"1998","unstructured":"Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE: Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 1998, 282: 490-493. 10.1126\/science.282.5388.490.","journal-title":"Science"},{"key":"202_CR45","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/BF01105085","volume":"287","author":"H Matsue","year":"1995","unstructured":"Matsue H, Kobayashi H, Hosokawa T, Akitaya T, Ohkawara A: Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN gamma-treated cultured keratinocytes. Arch Dermatol Res. 1995, 287: 315-320. 10.1007\/BF01105085.","journal-title":"Arch Dermatol Res"},{"key":"202_CR46","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.0022-202X.2004.23439.x","volume":"123","author":"A Nassif","year":"2004","unstructured":"Nassif A, Moslehi H, Le Gouvello S, Bagot M, Lyonnet L, Michel L, Boumsell L, Bensussan A, Roujeau JC: Evaluation of the potential role of cytokines in toxic epidermal necrolysis. J Invest Dermatol. 2004, 123: 850-855. 10.1111\/j.0022-202X.2004.23439.x.","journal-title":"J Invest Dermatol"},{"key":"202_CR47","doi-asserted-by":"publisher","first-page":"16183","DOI":"10.1074\/jbc.M212188200","volume":"278","author":"I Viard-Leveugle","year":"2003","unstructured":"Viard-Leveugle I, Bullani RR, Meda P, Micheau O, Limat A, Saurat JH, Tschopp J, French LE: Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions. J Biol Chem. 2003, 278: 16183-16188. 10.1074\/jbc.M212188200.","journal-title":"J Biol Chem"},{"key":"202_CR48","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jaci.2008.06.013","volume":"122","author":"J Murata","year":"2008","unstructured":"Murata J, Abe R, Shimizu H: Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment. J Allergy Clin Immunol. 2008, 122: 992-1000. 10.1016\/j.jaci.2008.06.013.","journal-title":"J Allergy Clin Immunol"},{"key":"202_CR49","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1084\/jem.187.8.1205","volume":"187","author":"P Schneider","year":"1998","unstructured":"Schneider P, Holler N, Bodmer JL, Hahne M, Frei K, Fontana A, Tschopp J: Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med. 1998, 187: 1205-1213. 10.1084\/jem.187.8.1205.","journal-title":"J Exp Med"},{"key":"202_CR50","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0002-9440(10)64284-8","volume":"162","author":"R Abe","year":"2003","unstructured":"Abe R, Shimizu T, Shibaki A, Nakamura H, Watanabe H, Shimizu H: Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am J Pathol. 2003, 162: 1515-1520.","journal-title":"Am J Pathol"},{"key":"202_CR51","doi-asserted-by":"crossref","first-page":"514","DOI":"10.7326\/0003-4819-151-7-200910060-00016","volume":"151","author":"R Abe","year":"2009","unstructured":"Abe R, Yoshioka N, Murata J, Fujita Y, Shimizu H: Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome. Ann Intern Med. 2009, 151: 514-515.","journal-title":"Ann Intern Med"},{"key":"202_CR52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","volume":"58","author":"S Halevy","year":"2008","unstructured":"Halevy S, Ghislain PD, Mockenhaupt M, Fagot JP, Bouwes Bavinck JN, Sidoroff A, Naldi L, Dunant A, Viboud C, Roujeau JC: Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol. 2008, 58: 25-32. 10.1016\/j.jaad.2007.08.036.","journal-title":"J Am Acad Dermatol"},{"key":"202_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"M Mockenhaupt","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, Sidoroff A, Schneck J, Roujeau JC, Flahault A: Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. 2008, 128: 35-44. 10.1038\/sj.jid.5701033.","journal-title":"J Invest Dermatol"},{"key":"202_CR54","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1212\/01.WNL.0000156354.20227.F0","volume":"64","author":"M Mockenhaupt","year":"2005","unstructured":"Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J: Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology. 2005, 64: 1134-1138.","journal-title":"Neurology"},{"key":"202_CR55","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1212\/WNL.49.2.542","volume":"49","author":"P Tennis","year":"1997","unstructured":"Tennis P, Stern RS: Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology. 1997, 49: 542-546.","journal-title":"Neurology"},{"key":"202_CR56","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/archderm.131.6.669","volume":"131","author":"F Guibal","year":"1995","unstructured":"Guibal F, Bastuji-Garin S, Chosidow O, Saiag P, Revuz J, Roujeau JC: Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy. Arch Dermatol. 1995, 131: 669-672. 10.1001\/archderm.131.6.669.","journal-title":"Arch Dermatol"},{"key":"202_CR57","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1542\/peds.2008-1923","volume":"123","author":"N Levi","year":"2009","unstructured":"Levi N, Bastuji-Garin S, Mockenhaupt M, Roujeau JC, Flahault A, Kelly JP, Martin E, Kaufman DW, Maison P: Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics. 2009, 123: e297-304. 10.1542\/peds.2008-1923.","journal-title":"Pediatrics"},{"key":"202_CR58","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.1365-2230.2008.02704.x","volume":"33","author":"EL Callaly","year":"2008","unstructured":"Callaly EL, FitzGerald O, Rogers S: Hydroxychloroquine-associated, photo-induced toxic epidermal necrolysis. Clin Exp Dermatol. 2008, 33: 572-574. 10.1111\/j.1365-2230.2008.02704.x.","journal-title":"Clin Exp Dermatol"},{"key":"202_CR59","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1600-0781.2005.00149.x","volume":"21","author":"AT Mansur","year":"2005","unstructured":"Mansur AT, Aydingoz IA: A case of toxic epidermal necrolysis with lesions mostly on sun-exposed skin. Photodermatol Photoimmunol Photomed. 2005, 21: 100-102. 10.1111\/j.1600-0781.2005.00149.x.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"202_CR60","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1046\/j.1365-2133.1996.d01-1111.x","volume":"135","author":"P Redondo","year":"1996","unstructured":"Redondo P, Vicente J, Espana A, Subira ML, De Felipe I, Quintanilla E: Photo-induced toxic epidermal necrolysis caused by clobazam. Br J Dermatol. 1996, 135: 999-1002. 10.1046\/j.1365-2133.1996.d01-1111.x.","journal-title":"Br J Dermatol"},{"key":"202_CR61","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/00006454-200102000-00022","volume":"20","author":"R Ball","year":"2001","unstructured":"Ball R, Ball LK, Wise RP, Braun MM, Beeler JA, Salive ME: Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system. Pediatr Infect Dis J. 2001, 20: 219-223. 10.1097\/00006454-200102000-00022.","journal-title":"Pediatr Infect Dis J"},{"key":"202_CR62","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1001\/archderm.136.3.323","volume":"136","author":"I Garcia-Doval","year":"2000","unstructured":"Garcia-Doval I, LeCleach L, Bocquet H, Otero XL, Roujeau JC: Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?. Arch Dermatol. 2000, 136: 323-327. 10.1001\/archderm.136.3.323.","journal-title":"Arch Dermatol"},{"key":"202_CR63","doi-asserted-by":"crossref","DOI":"10.3109\/9781841847665","volume-title":"Litt's Drug Eruptions and Reactions Manual","author":"JZ Litt","year":"2010","unstructured":"Litt JZ: Litt's Drug Eruptions and Reactions Manual., 16 2010. --- Either ISSN or Journal title must be supplied..","edition":"16"},{"key":"202_CR64","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","volume":"331","author":"JC Roujeau","year":"1994","unstructured":"Roujeau JC, Stern RS: Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994, 331: 1272-1285. 10.1056\/NEJM199411103311906.","journal-title":"N Engl J Med"},{"key":"202_CR65","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00004630-200203000-00004","volume":"23","author":"TL Palmieri","year":"2002","unstructured":"Palmieri TL, Greenhalgh DG, Saffle JR, Spence RJ, Peck MD, Jeng JC, Mozingo DW, Yowler CJ, Sheridan RL, Ahrenholz DH: A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century. J Burn Care Rehabil. 2002, 23: 87-96. 10.1097\/00004630-200203000-00004.","journal-title":"J Burn Care Rehabil"},{"key":"202_CR66","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1097\/00006534-199809040-00014","volume":"102","author":"T McGee","year":"1998","unstructured":"McGee T, Munster A: Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center. Plast Reconstr Surg. 1998, 102: 1018-1022. 10.1097\/00006534-199809040-00014.","journal-title":"Plast Reconstr Surg"},{"key":"202_CR67","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1097\/00006534-200209010-00008","volume":"110","author":"I Ducic","year":"2002","unstructured":"Ducic I, Shalom A, Rising W, Nagamoto K, Munster AM: Outcome of patients with toxic epidermal necrolysis syndrome revisited. Plast Reconstr Surg. 2002, 110: 768-773. 10.1097\/00006534-200209010-00008.","journal-title":"Plast Reconstr Surg"},{"key":"202_CR68","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2340\/00015555-0214","volume":"87","author":"SH Kardaun","year":"2007","unstructured":"Kardaun SH, Jonkman MF: Dexamethasone pulse therapy for Stevens-Johnson syndrome\/toxic epidermal necrolysis. Acta Derm Venereol. 2007, 87: 144-148. 10.2340\/00015555-0214.","journal-title":"Acta Derm Venereol"},{"key":"202_CR69","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","volume":"58","author":"J Schneck","year":"2008","unstructured":"Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M: Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol. 2008, 58: 33-40. 10.1016\/j.jaad.2007.08.039.","journal-title":"J Am Acad Dermatol"},{"key":"202_CR70","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","volume":"352","author":"P Wolkenstein","year":"1998","unstructured":"Wolkenstein P, Latarjet J, Roujeau JC, Duguet C, Boudeau S, Vaillant L, Maignan M, Schuhmacher MH, Milpied B, Pilorget A: Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet. 1998, 352: 1586-1589. 10.1016\/S0140-6736(98)02197-7.","journal-title":"Lancet"},{"key":"202_CR71","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1365-2133.2006.07436.x","volume":"155","author":"MR Namazi","year":"2006","unstructured":"Namazi MR: Increased mortality in toxic epidermal necrolysis with thalidomide: corroborating or exonerating the pathogenetic role of TNF-alpha?. Br J Dermatol. 2006, 155: 842-843. 10.1111\/j.1365-2133.2006.07436.x.","journal-title":"Br J Dermatol"},{"key":"202_CR72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archderm.139.1.33","volume":"139","author":"N Bachot","year":"2003","unstructured":"Bachot N, Revuz J, Roujeau JC: Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol. 2003, 139: 33-36. 10.1001\/archderm.139.1.33.","journal-title":"Arch Dermatol"},{"key":"202_CR73","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2340\/00015555-0249","volume":"87","author":"C Prins","year":"2007","unstructured":"Prins C, Gelfand EW, French LE: Intravenous immunoglobulin: properties, mode of action and practical use in dermatology. Acta Derm Venereol. 2007, 87: 206-218.","journal-title":"Acta Derm Venereol"},{"key":"202_CR74","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1365-4632.2004.02048.x","volume":"43","author":"N Al-Mutairi","year":"2004","unstructured":"Al-Mutairi N, Arun J, Osama NE, Amr Z, Mazen AS, Ibtesam el A, Nazeha el B: Prospective, noncomparative open study from Kuwait of the role of intravenous immunoglobulin in the treatment of toxic epidermal necrolysis. Int J Dermatol. 2004, 43: 847-851. 10.1111\/j.1365-4632.2004.02048.x.","journal-title":"Int J Dermatol"},{"key":"202_CR75","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/01.BCR.0000105096.93526.27","volume":"25","author":"KM Brown","year":"2004","unstructured":"Brown KM, Silver GM, Halerz M, Walaszek P, Sandroni A, Gamelli RL: Toxic epidermal necrolysis: does immunoglobulin make a difference?. J Burn Care Rehabil. 2004, 25: 81-88. 10.1097\/01.BCR.0000105096.93526.27.","journal-title":"J Burn Care Rehabil"},{"key":"202_CR76","first-page":"430","volume":"83","author":"E Campione","year":"2003","unstructured":"Campione E, Marulli GC, Carrozzo AM, Chimenti MS, Costanzo A, Bianchi L: High-dose intravenous immunoglobulin for severe drug reactions: efficacy in toxic epidermal necrolysis. Acta Derm Venereol. 2003, 83: 430-432.","journal-title":"Acta Derm Venereol"},{"key":"202_CR77","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/archderm.139.1.26","volume":"139","author":"C Prins","year":"2003","unstructured":"Prins C, Kerdel FA, Padilla RS, Hunziker T, Chimenti S, Viard I, Mauri DN, Flynn K, Trent J, Margolis DJ: Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol. 2003, 139: 26-32. 10.1001\/archderm.139.1.26.","journal-title":"Arch Dermatol"},{"key":"202_CR78","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/01.BCR.0000124746.33279.86","volume":"25","author":"R Shortt","year":"2004","unstructured":"Shortt R, Gomez M, Mittman N, Cartotto R: Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis. J Burn Care Rehabil. 2004, 25: 246-255. 10.1097\/01.BCR.0000124746.33279.86.","journal-title":"J Burn Care Rehabil"},{"key":"202_CR79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1346-8138.2005.tb00704.x","volume":"32","author":"AW Tan","year":"2005","unstructured":"Tan AW, Thong BY, Yip LW, Chng HH, Ng SK: High-dose intravenous immunoglobulins in the treatment of toxic epidermal necrolysis: an Asian series. J Dermatol. 2005, 32: 1-6.","journal-title":"J Dermatol"},{"key":"202_CR80","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/archderm.139.1.39","volume":"139","author":"JT Trent","year":"2003","unstructured":"Trent JT, Kirsner RS, Romanelli P, Kerdel FA: Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience. Arch Dermatol. 2003, 139: 39-43. 10.1001\/archderm.139.1.39.","journal-title":"Arch Dermatol"},{"issue":"8","key":"202_CR81","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1365-2230.2010.03826.x","volume":"35","author":"R Rajaratnam","year":"2010","unstructured":"Rajaratnam R, Mann C, Balasubramaniam P, Marsden JR, Taibjee SM, Shah F, Lim R, Papini R, Moiemen N, Lewis H: Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre. Clin Exp Dermatol. 2010, 35 (8): 853-862. 10.1111\/j.1365-2230.2010.03826.x.","journal-title":"Clin Exp Dermatol"},{"key":"202_CR82","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.burns.2006.08.014","volume":"33","author":"M Stella","year":"2007","unstructured":"Stella M, Clemente A, Bollero D, Risso D, Dalmasso P: Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis. Burns. 2007, 33: 452-459. 10.1016\/j.burns.2006.08.014.","journal-title":"Burns"},{"key":"202_CR83","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1586\/17469872.2.3.299","volume":"2","author":"JT Trent","year":"2007","unstructured":"Trent JT, Fangchao M, Kerdel F, Fie S, French LE, Romanelli p, Kirsner RS: Dose of intravenous immunoglobulin and patient survival in SJS and toxic epidermal necrolysis. Expert Review of Dermatology. 2007, 2: 299-303. 10.1586\/17469872.2.3.299.","journal-title":"Expert Review of Dermatology"},{"key":"202_CR84","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4103\/0378-6323.18943","volume":"71","author":"K Mangla","year":"2005","unstructured":"Mangla K, Rastogi S, Goyal P, Solanki RB, Rawal RC: Efficacy of low dose intravenous immunoglobulins in children with toxic epidermal necrolysis: an open uncontrolled study. Indian J Dermatol Venereol Leprol. 2005, 71: 398-400. 10.4103\/0378-6323.18943.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"202_CR85","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1067\/mjd.2002.127249","volume":"47","author":"P Tristani-Firouzi","year":"2002","unstructured":"Tristani-Firouzi P, Petersen MJ, Saffle JR, Morris SE, Zone JJ: Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children. J Am Acad Dermatol. 2002, 47: 548-552. 10.1067\/mjd.2002.127249.","journal-title":"J Am Acad Dermatol"},{"key":"202_CR86","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005373-200003000-00017","volume":"48","author":"JM Arevalo","year":"2000","unstructured":"Arevalo JM, Lorente JA, Gonzalez-Herrada C, Jimenez-Reyes J: Treatment of toxic epidermal necrolysis with cyclosporin A. J Trauma. 2000, 48: 473-478. 10.1097\/00005373-200003000-00017.","journal-title":"J Trauma"},{"key":"202_CR87","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4103\/0378-6323.41379","volume":"74","author":"R Rai","year":"2008","unstructured":"Rai R, Srinivas CR: Suprapharmacologic doses of intravenous dexamethasone followed by cyclosporine in the treatment of toxic epidermal necrolysis. Indian J Dermatol Venereol Leprol. 2008, 74: 263-265. 10.4103\/0378-6323.41379.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"202_CR88","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1080\/00015550310005906","volume":"84","author":"N Hashim","year":"2004","unstructured":"Hashim N, Bandara D, Tan E, Ilchyshyn A: Early cyclosporine treatment of incipient toxic epidermal necrolysis induced by concomitant use of lamotrigine and sodium valproate. Acta Derm Venereol. 2004, 84: 90-91. 10.1080\/00015550310005906.","journal-title":"Acta Derm Venereol"},{"key":"202_CR89","first-page":"31","volume":"32","author":"E Robak","year":"2001","unstructured":"Robak E, Robak T, Gora-Tybor J, Chojnowski K, Strzelecka B, Waszczykowska E, Sysa-Jedrzejowska A: Toxic epidermal necrolysis in a patient with severe aplastic anemia treated with cyclosporin A and G-CSF. J Med. 2001, 32: 31-39.","journal-title":"J Med"},{"issue":"4","key":"202_CR90","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1365-2133.2010.09863.x","volume":"163","author":"L Valeyrie-Allanore","year":"2010","unstructured":"Valeyrie-Allanore L, Wolkenstein P, Brochard L, Ortonne N, Maitre B, Revuz J, Bagot M, Roujeau J: Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. 2010, 163 (4): 847-853. 10.1111\/j.1365-2133.2010.09863.x.","journal-title":"Br J Dermatol"},{"key":"202_CR91","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jaci.2005.06.029","volume":"116","author":"RE Hunger","year":"2005","unstructured":"Hunger RE, Hunziker T, Buettiker U, Braathen LR, Yawalkar N: Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment. J Allergy Clin Immunol. 2005, 116: 923-924. 10.1016\/j.jaci.2005.06.029.","journal-title":"J Allergy Clin Immunol"},{"key":"202_CR92","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1468-3083.2006.02026.x","volume":"21","author":"F Meiss","year":"2007","unstructured":"Meiss F, Helmbold P, Meykadeh N, Gaber G, Marsch W, Fischer M: Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumour necrosis factor-alpha antibody infliximab: report of three cases. J Eur Acad Dermatol Venereol. 2007, 21: 717-719.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"202_CR93","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1001\/archderm.121.12.1548","volume":"121","author":"D Kamanabroo","year":"1985","unstructured":"Kamanabroo D, Schmitz-Landgraf W, Czarnetzki BM: Plasmapheresis in severe drug-induced toxic epidermal necrolysis. Arch Dermatol. 1985, 121: 1548-1549. 10.1001\/archderm.121.12.1548.","journal-title":"Arch Dermatol"},{"key":"202_CR94","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.bjps.2004.12.007","volume":"58","author":"M Lissia","year":"2005","unstructured":"Lissia M, Figus A, Rubino C: Intravenous immunoglobulins and plasmapheresis combined treatment in patients with severe toxic epidermal necrolysis: preliminary report. Br J Plast Surg. 2005, 58: 504-510. 10.1016\/j.bjps.2004.12.007.","journal-title":"Br J Plast Surg"},{"key":"202_CR95","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1744-9987.1998.tb00094.x","volume":"2","author":"H Yamada","year":"1998","unstructured":"Yamada H, Takamori K, Yaguchi H, Ogawa H: A study of the efficacy of plasmapheresis for the treatment of drug induced toxic epidermal necrolysis. Ther Apher. 1998, 2: 153-156. 10.1111\/j.1744-9987.1998.tb00094.x.","journal-title":"Ther Apher"},{"key":"202_CR96","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s001340051063","volume":"25","author":"A Furubacke","year":"1999","unstructured":"Furubacke A, Berlin G, Anderson C, Sjoberg F: Lack of significant treatment effect of plasma exchange in the treatment of drug-induced toxic epidermal necrolysis?. Intensive Care Med. 1999, 25: 1307-1310. 10.1007\/s001340051063.","journal-title":"Intensive Care Med"},{"key":"202_CR97","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1097\/00007611-199610000-00015","volume":"89","author":"NG Frangogiannis","year":"1996","unstructured":"Frangogiannis NG, Boridy I, Mazhar M, Mathews R, Gangopadhyay S, Cate T: Cyclophosphamide in the treatment of toxic epidermal necrolysis. South Med J. 1996, 89: 1001-1003. 10.1097\/00007611-199610000-00015.","journal-title":"South Med J"},{"key":"202_CR98","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S0190-9622(08)80969-3","volume":"25","author":"MC Heng","year":"1991","unstructured":"Heng MC, Allen SG: Efficacy of cyclophosphamide in toxic epidermal necrolysis. Clinical and pathophysiologic aspects. J Am Acad Dermatol. 1991, 25: 778-786. 10.1016\/S0190-9622(08)80969-3.","journal-title":"J Am Acad Dermatol"},{"key":"202_CR99","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/sj.eye.6701653","volume":"19","author":"LW Yip","year":"2005","unstructured":"Yip LW, Thong BY, Tan AW, Khin LW, Chng HH, Heng WJ: High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits. Eye (Lond). 2005, 19: 846-853.","journal-title":"Eye (Lond)"},{"key":"202_CR100","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/archotol.124.12.1375","volume":"124","author":"JE Barrera","year":"1998","unstructured":"Barrera JE, Meyers AD, Hartford EC: Hypopharyngeal stenosis and dysphagia complicating toxic epidermal necrolysis. Arch Otolaryngol Head Neck Surg. 1998, 124: 1375-1376.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"202_CR101","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/BF02343438","volume":"14","author":"TE Herman","year":"1984","unstructured":"Herman TE, Kushner DC, Cleveland RH: Esophageal stricture secondary to drug-induced toxic epidermal necrolysis. Pediatr Radiol. 1984, 14: 439-440. 10.1007\/BF02343438.","journal-title":"Pediatr Radiol"},{"key":"202_CR102","first-page":"53","volume":"3","author":"A Romano","year":"1993","unstructured":"Romano A, Di Fonso M, Pocobelli D, Giannarini L, Venuti A, Garcovich A: Two cases of toxic epidermal necrolysis caused by delayed hypersensitivity to beta-lactam antibiotics. J Investig Allergol Clin Immunol. 1993, 3: 53-55.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"202_CR103","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1001\/archderm.119.11.910","volume":"119","author":"H Tagami","year":"1983","unstructured":"Tagami H, Tatsuta K, Iwatski K, Yamada M: Delayed hypersensitivity in ampicillin-induced toxic epidermal necrolysis. Arch Dermatol. 1983, 119: 910-913. 10.1001\/archderm.119.11.910.","journal-title":"Arch Dermatol"},{"key":"202_CR104","first-page":"47","volume":"25","author":"VM Asensio-Sanchez","year":"2008","unstructured":"Asensio-Sanchez VM: [Toxic epidermal necrolysis following dorzolamide eyedrops]. An Med Interna. 2008, 25: 47-48.","journal-title":"An Med Interna"},{"key":"202_CR105","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0151-9638(07)92849-5","volume":"134","author":"JL Schmutz","year":"2007","unstructured":"Schmutz JL, Barbaud A, Trechot P: [Polymorphous bullous erythema and trihexiphenidyl (or why police questioning is not always the most productive method)]. Ann Dermatol Venereol. 2007, 134: 899-10.1016\/S0151-9638(07)92849-5.","journal-title":"Ann Dermatol Venereol"},{"key":"202_CR106","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1600-0536.1996.tb02364.x","volume":"35","author":"P Wolkenstein","year":"1996","unstructured":"Wolkenstein P, Chosidow O, Flechet ML, Robbiola O, Paul M, Dume L, Revuz J, Roujeau JC: Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis. 1996, 35: 234-236. 10.1111\/j.1600-0536.1996.tb02364.x.","journal-title":"Contact Dermatitis"},{"key":"202_CR107","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/j.1398-9995.2004.00547.x","volume":"59","author":"WJ Pichler","year":"2004","unstructured":"Pichler WJ, Tilch J: The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy. 2004, 59: 809-820. 10.1111\/j.1398-9995.2004.00547.x.","journal-title":"Allergy"},{"key":"202_CR108","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1111\/j.1398-9995.2007.01553.x","volume":"62","author":"Y Kano","year":"2007","unstructured":"Kano Y, Hirahara K, Mitsuyama Y, Takahashi R, Shiohara T: Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption. Allergy. 2007, 62: 1439-1444. 10.1111\/j.1398-9995.2007.01553.x.","journal-title":"Allergy"},{"key":"202_CR109","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1398-9995.2007.01516.x","volume":"63","author":"A Beeler","year":"2008","unstructured":"Beeler A, Zaccaria L, Kawabata T, Gerber BO, Pichler WJ: CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivity. Allergy. 2008, 63: 181-188.","journal-title":"Allergy"},{"issue":"3","key":"202_CR110","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1398-9995.2009.02180.x","volume":"65","author":"A Zawodniak","year":"2009","unstructured":"Zawodniak A, Lochmatter P, Yerly D, Kawabata T, Lerch M, Yawalkar N, Pichler WJ: In vitro detection of cytotoxic T and NK cells in peripheral blood of patients with various drug-induced skin diseases. Allergy. 2009, 65 (3): 376-84. 10.1111\/j.1398-9995.2009.02180.x.","journal-title":"Allergy"},{"key":"202_CR111","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","volume":"115","author":"S Bastuji-Garin","year":"2000","unstructured":"Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P: SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol. 2000, 115: 149-153. 10.1046\/j.1523-1747.2000.00061.x.","journal-title":"J Invest Dermatol"},{"key":"202_CR112","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000148255","volume":"217","author":"SJ Yun","year":"2008","unstructured":"Yun SJ, Choi MS, Piao MS, Lee JB, Kim SJ, Won YH, Lee SC: Serum lactate dehydrogenase is a novel marker for the evaluation of disease severity in the early stage of toxic epidermal necrolysis. Dermatology. 2008, 217: 254-259. 10.1159\/000148255.","journal-title":"Dermatology"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-5-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1750-1172-5-39\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-5-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T15:17:31Z","timestamp":1712071051000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-5-39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":112,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["202"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-5-39","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]},"article-number":"39"}}